Hoth Therapeutics Inc (HOTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,781 | -5,675 | -3,476 | -8,188 | -6,086 |
| Depreciation Amortization | N/A | N/A | 4 | N/A | N/A |
| Accounts payable and accrued liabilities | 196 | -460 | -16 | 153 | 129 |
| Other Working Capital | -160 | -615 | -387 | 405 | 331 |
| Other Operating Activity | 2,092 | 1,589 | 1,087 | 652 | 675 |
| Operating Cash Flow | $-7,654 | $-5,161 | $-2,788 | $-6,978 | $-4,950 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -300 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -300 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-300 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,137 | 7,133 | 7,067 | 4,743 | 3,682 |
| Other Financing Activity | -376 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $8,761 | $7,133 | $7,067 | $4,743 | $3,682 |
| Exchange Rate Effect | 2 | 3 | -1 | -18 | -2 |
| Beginning Cash Position | 7,039 | 7,039 | 7,039 | 9,292 | 9,292 |
| End Cash Position | 7,848 | 9,014 | 11,317 | 7,039 | 8,023 |
| Net Cash Flow | $809 | $1,975 | $4,278 | $-2,253 | $-1,270 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,654 | -5,161 | -2,788 | -6,978 | -4,950 |
| Free Cash Flow | -7,654 | -5,161 | -2,788 | -6,978 | -4,950 |